NCT02238496 2023-05-25
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Columbia University
Phase 1 Completed
Columbia University
City of Hope Medical Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)